| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | -37.0% | -83.2% |
| Cost of Revenue | $1.5M | -39.8% | -55.7% |
| Gross Profit | $1.5M | -33.8% | -89.8% |
| R&D Expense | $64K | -60.5% | -40.8% |
| SG&A Expense | $1.4M | -11.4% | -29.6% |
| Operating Income | -$11K | -110.4% | -100.1% |
| Interest Expense | $3K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.5M | — | +17.8% |
| Short-term Investments | $2.9M | +16.4% | -60.5% |
| Accounts Receivable | $1.1M | -63.1% | -57.1% |
| Current Assets | $12.6M | +41.3% | +2.9% |
| Total Assets | $13.3M | -1.4% | -47.6% |
| Current Liabilities |
| -19.2% |
| Pre-tax Income | -$134K | -112.6% | -101.2% |
| Income Tax | $3K | +194.7% | -98.5% |
| Net Income | $434K | -60.5% | -96.1% |
| EPS (Basic) | $0.02 | -60.0% | -96.2% |
| EPS (Diluted) | $0.02 | -50.0% | -96.2% |
| $9.0M |
| +26.9% |
| +37.9% |
| Long-term Debt | $511K | -65.7% | -72.5% |
| Total Liabilities | $9.5M | -4.6% | -14.7% |
| Stockholders' Equity | $5.2M | +7.3% | -58.1% |